Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001082452 | SCV000287551 | likely benign | Colorectal cancer, susceptibility to, 10 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000657092 | SCV000568934 | likely benign | not provided | 2019-12-18 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000481096 | SCV000601902 | likely benign | not specified | 2016-12-02 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000481096 | SCV002761041 | uncertain significance | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004943792 | SCV005476225 | benign | Hereditary cancer-predisposing syndrome | 2024-06-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004529393 | SCV000806487 | likely benign | POLD1-related disorder | 2022-02-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |